Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 9, 830

Targeting Head and Neck Cancer by Vaccination


Targeting Head and Neck Cancer by Vaccination

Chuan Wang et al. Front Immunol.


Head and neck cancer (HNC) is a heterogeneous group of squamous cell cancers that affect the oral cavity, pharynx, and larynx. Worldwide, it is the sixth most common cancer but in parts of Southern and South-East Asia, HNC is one of the most common cancers. A significant proportion of HNC is driven by human papillomavirus (HPV) infection, whereas HPV-independent HNC is associated with alcohol, smoking, and smokeless tobacco consumption. Here, we review the past and present experience of targeting HNC with vaccination focusing on HPV-derived antigens as well as non-viral antigens for HPV-negative HNC. Novel therapeutic approaches for HNC will focus not only on effective vaccine platforms but will also target the stroma-rich immunosuppressive microenvironment found in those tumours.

Keywords: cancer antigens; cancer vaccines; head and neck cancer; human papillomavirus; human papillomavirus independent.


Figure 1
Figure 1
Approaches for prophylactic (A) and therapeutic (B) vaccination for head and neck cancer. Abbreviations: VLP, virus-like particle; iTME, immunosuppressive tumour microenvironment; MDSC, myeloid-derived suppressor cell; Treg, regulatory T cell; CAF, cancer-associated fibroblast.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles


    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin (2011) 61(2):69–90.10.3322/caac.20107 - DOI - PubMed
    1. Warnakulasuriya S. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol (2010) 46(6):407–10.10.1016/j.oraloncology.2010.02.015 - DOI - PubMed
    1. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 31(36):4550–9.10.1200/JCO.2013.50.3870 - DOI - PMC - PubMed
    1. Mishra A, Meherotra R. Head and neck cancer: global burden and regional trends in India. Asian Pac J Cancer Prev (2014) 15(2):537–50.10.7314/APJCP.2014.15.2.537 - DOI - PubMed
    1. Chye GLC, Rampal S, Yahaya H, Latif AZA, Jalil AA, Bustam A, et al. Cancer Incidence in Peninsular Malaysia, 2003–2005. Kuala Lumpur: National Cancer Registry; (2008). p. 38–176.

Publication types